Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease.

Date AA, Halpert G, Babu T, Ortiz J, Kanvinde P, Dimitrion P, Narayan J, Zierden H, Betageri K, Musmanno O, Wiegand H, Huang X, Gumber S, Hanes J, Ensign LM. Mucus-penetrating budesonide nanosuspension enema for local treatment of inflammatory bowel disease. Biomaterials. 2018 12; 185:97-105.

View in: PubMed

subject areas

Animals
Anti-Inflammatory Agents
Budesonide
Colon
Drug Compounding
Drug Delivery Systems
Enema
Inflammatory Bowel Diseases
Male
Mice
Mice, Inbred C57BL
Mucus
Nanoparticles
Poloxamer
Polystyrenes
Suspensions
Trinitrobenzenesulfonic Acid

authors with profiles

Abhijit Date, PhD

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support